Search results
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
Why Is My Scalp Flaky? Exploring The Causes Of Dandruff And How It’s Treated
IFLScience· 6 days agoDandruff is a harmless – if irritating – condition that usually affects the skin of the scalp,...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 4 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
Mizuho Boosts Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $18.00
ETF DAILY NEWS· 7 days agoArcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $17.00 to $18.00 in a report issued on Wednesday, Benzinga reports. They currently have a buy rating ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 4 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...